Skip to main content
logo
Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.65
+0.03 (0.22%)
At close: Aug 11, 2026, 4:00 PM EDT
13.65
0.00 (0.00%)
Pre-market: Aug 12, 2026, 7:38 AM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Women's Health Revenue
1.64B1.75B1.78B
Biosimilars Revenue
745.00M691.00M662.00M
Established Brands Revenue
3.68B3.69B3.85B
Other Product Group Revenue
68.00M82.00M115.00M
Revenue (Total)
6.13B6.22B6.40B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
United States Revenue
1.53B1.60B1.57B
Europe and Canada Revenue
1.67B1.62B1.76B
Asia Pacific and Japan Revenue
957.00M1.00B1.05B
China Revenue
823.00M829.00M847.00M
Latin America, Middle East, Russia and Africa Revenue
1.06B1.07B1.03B
Other International Revenue
83.00M93.00M137.00M
International Revenue
4.59B4.61B4.83B
Revenue (Total)
6.13B6.22B6.40B